跳至主要内容
临床试验/NCT01654458
NCT01654458已完成不适用

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Women's College Hospital7 个研究点 分布在 2 个国家目标入组 398 人开始时间: 2012年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
398
试验地点
7
主要终点
Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R).

研究概览

简要总结

There is a high prevalence of sexual and body image problems among women treated for gynecologic cancer, which can lead to considerable distress. Given the sensitive and highly personal nature of these problems, women are often reluctant to speak to their doctors about these concerns and have few resources for support and information. The research team will conduct a prospective randomized controlled trail (RCT) to test the benefits of "GyneGals," a 12-week online (i.e. Internet-based) support group intervention for women who are sexually distressed due to gynecologic cancer and its treatment.

The primary aim of this study is to determine whether a professionally-facilitated, information-rich, online support group is beneficial for women who are sexually distressed due to gynecologic cancer and the side effects of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Received surgical, radiation or chemotherapy treatments for any gynecologic cancer
  • •Not receiving active treatment
  • •Currently disease-free for a minimum of 3 months
  • •No more than 5 years post-diagnosis
  • •Distressed due to psychosexual concerns related to cancer
  • •Willing to discuss psychosexual concerns
  • •18 years or older
  • •Has access to a computer and the Internet
  • •Speaks, reads, and writes in English
  • •Provides informed consent

排除标准

  • •Acutely suicidal (i.e., actively suicidal within the previous 3 months)
  • •Has a major psychiatric illness

研究组 & 干预措施

Immediate Treatment Condition

Experimental

Receives the 12-week GyneGals Support Group within a month of completing the baseline assessment.

干预措施: GyneGals Support Group (Behavioral)

Waitlist Control Condition

No Intervention

Waitlist control group receives the 12-week GyneGals Support Group only after its involvement in the study has ended, as a courtesy.

结局指标

主要结局

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R).

时间窗: 9 months

13-item self-report scale that measures sexually-related distress in women.

次要结局

  • Body image, as measured by the Sexual Adjustment and Body Image Scale - Gynecologic Cancer (SABIS-G).(9 months (at months 1, 5, and 9))
  • Depression and anxiety symptoms, as measured by the Hospital Anxiety and Depression Scale (HADS).(9 months (at months 1, 5, and 9))
  • Relationship satisfaction, as measured by the Relationship Assessment Scale (RAS).(9 months (at months 1, 5, and 9))
  • Perceived social support, as measured by MOS Social Support Survey (MOS-SS).(9 months (at months 1, 5, and 9))
  • Sexual function, as measured by the Sexual Function Questionnaire (SFQ).(9 months (at months 1, 5, and 9))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

已完成
不适用
The Impact of Mindful Compassion on Sexual Functioning Post Breast Cancer TreatmentSexual Functioning
NCT06046716London Metropolitan University52
已完成
不适用
Evaluation of an Online Intervention for Female Sexual DysfunctionFemale Sexual Dysfunction
NCT06237166Gaia AG252
已完成
不适用
A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University StudentsEating DisordersBody Image DisorderBody Dysmorphic Disorders
NCT04103606University of Padova100
进行中(未招募)
不适用
Sexual Health and Rehabilitation Online (SHAREonline)Cancer SurvivorshipSexual Function Disturbances
NCT06458049Dana-Farber Cancer Institute84
已完成
2 期
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerStage IIA Ovarian Germ Cell TumorBreast CancerOvarian SarcomaStage I Uterine SarcomaStage I Vulvar CancerStage IA Ovarian Epithelial CancerStage IC Fallopian Tube CancerStage IIA Fallopian Tube CancerStage IIIA Ovarian Germ Cell TumorStage IIIB Endometrial CarcinomaStage IIIB Fallopian Tube CancerStage IIIB Primary Peritoneal Cavity CancerOvarian Stromal CancerStage I Vaginal CancerStage IA Primary Peritoneal Cavity CancerStage IB Ovarian Epithelial CancerStage IC Ovarian Epithelial CancerStage IC Ovarian Germ Cell TumorStage II Endometrial CarcinomaStage II Uterine SarcomaStage IIA Primary Peritoneal Cavity CancerStage IIB Ovarian Germ Cell TumorStage IIC Ovarian Germ Cell TumorStage III Uterine SarcomaStage IIIA Cervical CancerStage IIIA Endometrial CarcinomaStage IIIA Fallopian Tube CancerStage IIIB Ovarian Germ Cell TumorStage IIIC Ovarian Epithelial CancerStage IIIC Primary Peritoneal Cavity CancerStage IA Cervical CancerStage IA Endometrial CarcinomaStage IB Primary Peritoneal Cavity CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIB Cervical CancerStage IIIA Ovarian Epithelial CancerStage IIIC Endometrial CarcinomaStage IA Fallopian Tube CancerStage IB Cervical CancerStage IB Endometrial CarcinomaStage IB Fallopian Tube CancerStage IB Ovarian Germ Cell TumorStage IC Primary Peritoneal Cavity CancerStage II Vaginal CancerStage IIA Ovarian Epithelial CancerStage IIB Fallopian Tube CancerStage IIB Primary Peritoneal Cavity CancerStage IIC Ovarian Epithelial CancerStage IIC Primary Peritoneal Cavity CancerStage III Gestational Trophoblastic TumorStage III Vaginal CancerStage III Vulvar CancerStage IIIA Primary Peritoneal Cavity CancerStage IIIB Cervical CancerStage IIIB Ovarian Epithelial CancerStage IIIC Ovarian Germ Cell TumorStage IA Ovarian Germ Cell TumorStage II Gestational Trophoblastic TumorStage IIB Ovarian Epithelial CancerStage IIC Fallopian Tube CancerStage IIIC Fallopian Tube Cancer
NCT01764802Ohio State University Comprehensive Cancer Center100